← Back to headlines
Candel Therapeutics and Cellectar Biosciences Miss EPS Estimates
Candel Therapeutics reported a GAAP EPS of -$0.52, missing estimates by $0.29, while Cellectar Biosciences reported a GAAP EPS of -$0.57, missing by $0.05.
13 Aug, 12:12 — 13 Aug, 12:12
Sources
Showing 1 of 1 sources
